开能健康
(300272)
| 流通市值:23.20亿 | | | 总市值:31.06亿 |
| 流通股本:4.57亿 | | | 总股本:6.11亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,372,319,849.5 | 921,118,737.51 | 417,607,625.01 | 1,840,952,624.84 |
| 营业收入 | 1,372,319,849.5 | 921,118,737.51 | 417,607,625.01 | 1,840,952,624.84 |
| 二、营业总成本 | 1,259,468,320.94 | 825,462,925.44 | 393,118,703.78 | 1,681,399,925.52 |
| 营业成本 | 826,274,679.38 | 538,051,024.18 | 256,787,960.48 | 1,122,582,731.97 |
| 税金及附加 | 7,252,221.17 | 4,846,277.23 | 2,853,811.42 | 10,624,014.54 |
| 销售费用 | 139,695,865.58 | 94,603,144.66 | 43,440,755.17 | 184,772,768.81 |
| 管理费用 | 178,605,542.36 | 118,079,402.31 | 54,071,738.08 | 242,491,979.49 |
| 研发费用 | 59,082,433.81 | 37,495,841.29 | 17,423,008.64 | 83,136,987.95 |
| 财务费用 | 48,557,578.64 | 32,387,235.77 | 18,541,429.99 | 37,791,442.76 |
| 其中:利息费用 | 29,992,167.56 | 20,429,783.04 | 10,691,497.51 | 44,868,760.72 |
| 其中:利息收入 | 16,110,564.6 | 12,587,708.82 | 4,772,796.75 | 24,211,743.17 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -58,067,520.8 | -1,227,279 | -1,103,068 | -14,053,615.04 |
| 加:投资收益 | -21,362,880.3 | -14,248,936.72 | -8,457,761.75 | -41,827,993.06 |
| 净敞口套期收益 | 0 | 0 | 0 | - |
| 资产处置收益 | 595,774.79 | 541,338.79 | 553,371.52 | -135,597.97 |
| 资产减值损失(新) | -791,392.63 | -784,076.09 | -141,889.8 | -1,962,397.03 |
| 信用减值损失(新) | -423,077.73 | 464,555.77 | 1,460,267.43 | -3,050,477.94 |
| 其他收益 | 8,053,856.93 | 5,764,039.3 | 2,421,667.31 | 11,768,527.75 |
| 四、营业利润 | 40,856,288.82 | 86,165,454.12 | 19,221,507.94 | 110,291,146.03 |
| 加:营业外收入 | 3,538,829.39 | 3,503,372.45 | 5,200.02 | 2,669,043.21 |
| 减:营业外支出 | 1,643,766.05 | 1,368,167.58 | 497,762.08 | 2,768,686.51 |
| 五、利润总额 | 42,751,352.16 | 88,300,658.99 | 18,728,945.88 | 110,191,502.73 |
| 减:所得税费用 | 24,397,147.77 | 22,744,911.82 | 5,911,176.79 | 30,120,353.95 |
| 六、净利润 | 18,354,204.39 | 65,555,747.17 | 12,817,769.09 | 80,071,148.78 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 18,354,204.39 | 65,555,747.17 | 12,817,769.09 | 80,071,148.78 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -11,738,814.43 | 40,405,324.32 | 5,343,350.8 | 56,008,942.61 |
| 少数股东损益 | 30,093,018.82 | 25,150,422.85 | 7,474,418.29 | 24,062,206.17 |
| 扣除非经常损益后的净利润 | -27,093,523.26 | 25,213,995.42 | 4,551,261.98 | 78,913,170.56 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.02 | 0.07 | 0.01 | 0.1 |
| (二)稀释每股收益 | -0.02 | 0.07 | 0.01 | 0.1 |
| 八、其他综合收益 | -9,202,864.03 | -6,460,308.63 | -2,799,659.97 | -3,903,463.47 |
| 归属于母公司股东的其他综合收益 | -6,048,519.55 | -4,300,781.61 | -1,946,246.63 | -3,354,732.92 |
| 九、综合收益总额 | 9,151,340.36 | 59,095,438.54 | 10,018,109.12 | 76,167,685.31 |
| 归属于母公司股东的综合收益总额 | -17,787,333.98 | 36,104,542.71 | 3,397,104.17 | 52,654,209.69 |
| 归属于少数股东的综合收益总额 | 26,938,674.34 | 22,990,895.83 | 6,621,004.95 | 23,513,475.62 |
| 公告日期 | 2026-10-23 | 2026-08-28 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |